Changes to Pharma Distribution in the UK Potentially Problematic.FARMINGTON, Conn. -- The Infoshop (http://www.the-infoshop.com/ee/54267) has announced the addition of Decision resources, Inc.'s product Pharmaceutical Distribution in Europe: Pfizer Breaks the Mold to its online catalog Similar to an online library or databases in the information storage respect, ‘’’online catalogs’’’ allow potential customers to browse a company’s items for sale from a different location using the internet. . Beginning March 2007, Pfizer introduced a direct distribution system for its products in the United Kingdom, making them available only from the company's sole appointed distributor rather than from a choice of wholesalers. This approach, should it prove successful, threatens to overturn the established model of pharmaceutical distribution, imposing enormous changes upon key stakeholder stakeholder n. a person having in his/her possession (holding) money or property in which he/she has no interest, right or title, awaiting the outcome of a dispute between two or more claimants to the money or property. groups-wholesalers, pharmacists This is a list of notable pharmacists.
provision of drugs or medicines as set out properly on a lawful prescription. A prescription can only be filled, the drugs supplied, by a registered pharmacist, veterinarian, dentist or member of the medical profession. doctors, and government. Like Pfizer, two-thirds of pharmaceutical companies have considered changes to their European distribution systems, threatening what was in 2004 a $130 billion pharmaceutical wholesale market for the region. What other pharma companies are considering a switch to direct distribution, and why? How are wholesalers adjusting their practices in anticipation of such a change in the business environment? Pfizer has reduced the discounts it provides to purchasers, changing from a percentage of the purchase value to a flat fee per pack; other companies considering direct-to-pharmacy (DTP See desktop publishing. DTP - desktop publishing ) distribution may follow suit. What recourse The right of an individual who is holding a Commercial Paper, such as a check or promissory note, to receive payment on it from anyone who has signed it if the individual who originally made it is unable, or refuses, to tender payment. do pharmacists and prescribers have in the face of this revenue loss? What government involvement, if any, might help offset this loss? What impact could this have on services provided? In 1991, GlaxoSmithKline (then-Glaxo) introduced a direct distribution program in the United Kingdom, an excursion excursion /ex·cur·sion/ (eks-kur´zhun) a range of movement regularly repeated in performance of a function, e.g., excursion of the jaws in mastication. that may provide some insight into potential outcomes of Pfizer's current venture. What changes has the company made to this system in the intervening 16 years? How have wholesalers and pharmacists responded to this program? For more information visit http://www.the-infoshop.com/ee/54267 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion